Seraxis

BiotechnologySeries CGermantown, USseraxis.com

Latest round

Series C

Last raised

Feb 2021

Total raised

$40M

Investors

8

About Seraxis

Founded in 2013 and based in Germantown, Maryland, Seraxis Inc. operates as a biotechnology company that focuses on cell therapy treatment for diabetes. Mr. William L. Rust is the CEO and co-founder of the company and Miss Carole Welsch is the co-founder and chief business officer.P. and East West Capital Partners. Seraxis team of scientists developed novel cell and encapsulation technologies. The company provides insulin-dependent diabetes. The company develops SR1423 cells, lab-grown islets for transplant and SeraGraft © device. The company has also developed SeraGraft, an implant device and method that enables survival and function of the cell replacement therapy in the absence of immune suppression. The company will focus on completing the preclinical testing of SR-01, Seraxis’ lead cell therapy treatment for insulin-dependent diabetes and initiate first-in-human clinical trials.

Who invested in Seraxis

8 investors across 2 rounds

See all investors in Seraxis

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Feb 9, 2021

    Amount

    $40M

    Investors

    Locked

  2. Series A

    Mar 1, 2013

    Amount

    Undisclosed

    Investors

    Locked

Questions about Seraxis

Who invested in Seraxis?

Seraxis has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Seraxis raised?

Seraxis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Seraxis last raise money?

Seraxis's most recent round on record is a Series C, in Feb 2021.

What does Seraxis do?

Founded in 2013 and based in Germantown, Maryland, Seraxis Inc.

Where is Seraxis headquartered?

Seraxis is headquartered in Germantown, US.

Which VCs invest in companies like Seraxis?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seraxis's stage. Their profiles are linked below.

Raising like Seraxis? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.